Control of pharmacokinetics of radioimmunoconjugates using chelating agents containing poly(ethylene glycol).

Radioimmunoconjugates (RICs) composed of a monoclonal antibody (mAb) and radioisotope (RI) offer an attractive modality in oncology; however, their low tumor/blood ratio has limited their utility. To establish a novel strategy to improve the tumor/bl…

Preview only. Read the full abstract at the source